Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Immunol. 2014 Mar 21;192(9):4263–4272. doi: 10.4049/jimmunol.1303185

FIGURE 5.

FIGURE 5

hip1 mutant augments antigen presentation by BMDCs. Purified C57BL/6J BMDCs in medium alone (ui) or infected with heat-killed wild type (wt) or hip1 mutant at MOI=10 for 24 hours were co-cultured with ESAT-61–20 peptide and ESAT-6 specific transgenic CD4 T cells (A) or OVA323–339 peptide and OT-II specific transgenic CD4 T cells for 3 days (B). Cell-free supernatants were collected and assayed for IFN-γ and IL-2 by ELISA. Data are representative of three independent experiments. Values are presented as mean +/− SD. *, p <0.05; **, p<0.01; ***, p<0.001.